Overview

Pacemakers Market is poised to value USD 5560.28 million by 2028 end at a CAGR of 3.4% during the forecast period 2022 to 2028. 

Increasing cases of cardiac conditions and the latest technological advancements in pacemaker devices are accelerating market growth. The increasing availability of medical coverage coupled with rising cases of cardiovascular diseases is expected to bolster the market. According to the figures released by the World Health Organization, an estimated 17 million people die of CVDs, particularly heart attacks and strokes, every year. High mortality rates linked with cardiac conditions are triggering the growth of the market. Increasing awareness among the population regarding cardiovascular disorders and its long term impact is expected to propel the market.

Increase in research and development initiatives and favourable government policies are expected to fuel the market growth. Under the Medicare Plan in the US, eligible professionals get an reimbursement, approximately USD 7,500 out of USD 10,000. Such initiatives are expected to spike the growth of the market. 

FutureWise Market Research has instantiated a report that provides an intricate analysis of Pacemakers Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Pacemakers Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Prominent players of the market are Medtronic, Abbott Laboratories, Boston Scientific, Biotronik, Livanova, Lepu Medical, Shree Pacetronix, Osypka Medical, Medico Spa, Oscor.

Pacemakers Market Segmentation:

By Type

• MRI Compatible Pacemaker
• Conventional Pacemaker

By Technology

• Single-chamber Pacemaker
• Dual-chamber Pacemaker
• Biventricular/CRT Pacemaker

By Implantability

• Implantable Pacemaker
• External Pacemaker

By End User

• Hospitals & Cardiac Centers
• Ambulatory Surgical Centers

By Region 

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Competitive Landscape:

• New product development is bolstering the market. The US FDA approved St.Jude Medical's SyncAV. SyncAV is a CRT software which is compatible with St. Jude Medical's multiPoint pacing technology
• FDA approved Medtronic's Azure pacemaker which comes with BlueSync technology
• Medtronic received certification from CE Mark for its upcoming next generation cardiac resynchronization therapy-pacemakers
• Abbott Laboratories received FDA approval for Assurity MRI Pacemakers

FutureWise Key Takeaways

• Growth Prospects
• SWOT Analysis
• Key Trends
• Key data-points affecting market growth

Objectives of the Study

• To provide with an exhaustive analysis on the pacemakers market by type, by technology, by implantability, by end user and by region. 
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• Evaluate and forecast micro-markets and the overall market 
• To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America and Middle East and Africa
• To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
• Profiling of companies to evaluate their market shares, strategies, financial and core competencies

Flexible Delivery Model:

• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
        1.1. Objectives of the Study 
        1.2. Market Definition 
        1.3. Market Scope 
               1.3.1. Years Considered for the Study
               1.3.2. Market Covered
        1.4. Currency 
        1.5. Limitations 
        1.6. Stakeholders 
 2.  Research Methodology 
        2.1. Research Data 
               2.1.1. Secondary Data
                          2.1.1.1. Key Data from Secondary Sources
               2.1.2. Primary Data
         2.1.2.1. Key Data from Primary Sources
        2.2. Market Size Estimation 
        2.3. Market Breakdown and Data Triangulation 
        2.4. Assumptions for the Study  
3. Executive Summary
        3.1. Market Outlook
        3.2. Segment Outlook
        3.3. Competitive Insights
4. Pacemakers Market Variables, Trends & Scope
        4.1. Market Lineage Outlook
        4.2. Penetration and Growth Prospect Mapping
        4.3. Industry Value Chain Analysis
        4.4. Cost Analysis Breakdown
        4.5. Technology Overview
        4.6. Regulatory Framework
                 4.6.1. Reimbursement Framework
                 4.6.2. Standards and Compliances
5. Pacemakers Market Overview
        5.1. Market Dynamics
                  5.1.1. Market Driver Analysis
                            5.1.1.1. Increasing focus of Pacemakers Companies on Brand Protection
                            5.1.1.2. Untapped Opportunities in Emerging Regions
                  5.1.2. Market Restraint Analysis
                            5.1.2.1. High Cost Associated with Implementation of Predictive Analysis
                  5.1.3. Industry Challenges
                            5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Pacemakers Market Analysis Tools
        6.1. Industry Analysis - Porter’s
               6.1.1. Supplier Power
               6.1.2. Buyer Power
               6.1.3. Substitution Threat
               6.1.4. Threat from New Entrants
               6.1.5. Competitive Rivalry
        6.2. Pestel Analysis
               6.2.1. Political Landscape
               6.2.2. Environmental Landscape
               6.2.3. Social Landscape
               6.2.4. Technology Landscape
               6.2.5. Legal Landscape
        6.3. Major Deals And Strategic Alliances Analysis
                6.3.1. Joint Ventures
                6.3.2. Mergers and Acquisitions
                6.3.3. Licensing and Partnership
                6.3.4. Technology Collaborations
                6.3.5. Strategic Divestments
        6.4. Market Entry Strategies
        6.5. Case Studies
7. Pacemakers Market, By Type Historical Analysis and Forecast 2022-2028 (USD Million)
        7.1 MRI Compatible Pacemaker
        7.2 Conventional Pacemaker         
8. Pacemakers Market, By Technology Historical Analysis and Forecast 2022-2028 (USD Million)
        8.1 Single-chamber Pacemaker
        8.2 Dual-chamber Pacemaker
        8.3 Biventricular/CRT Pacemaker
9. Pacemakers Market, By Implantability Historical Analysis and Forecast 2022-2028 (USD Million)
        9.1 Implantable Pacemaker
        9.2 External Pacemaker
10. Pacemakers Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million)
        10.1. Hospitals & Cardiac Centers
        10.2. Ambulatory Surgical Centers
11. North America Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
        11.1. Introduction
        11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
                  11.2.1. U.S.A
                  11.2.2. Canada
                  11.2.3. Mexico
        11.3. Market Size (USD Million) Forecast for North America 2022-2028 
12. Latin America Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
        12.1. Introduction
        12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
                 12.2.1. Brazil
                 12.2.2. Venezuela
                 12.2.3. Argentina
                 12.2.4. Rest of Latin America
        12.3. Market Size (USD Million) Forecast for Latin America 2022-2028  
13. Europe Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
        13.1. Introduction
        13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
                  13.2.1. Germany
                  13.2.2. U.K
                  13.2.3. France
                  13.2.4. Italy
                  13.2.5. Spain
                  13.2.6. Russia
                  13.2.7. Poland
                  13.2.8. Rest of Europe
        13.3. Market Size (USD Million) Forecast for Europe 2022-2028
14. Asia Pacific Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
        14.1. Introduction
        14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
                  14.2.1. Japan
                  14.2.2. China
                  14.2.3. India
                  14.2.4. Australia and New Zealand
                  14.2.5. ASEAN
                  14.2.6. Rest of Asia Pacific
        14.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028
15. Middle East and Africa Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
        15.1. Introduction
        15.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
                  15.2.1. Saudi Arabia
                  15.2.2. UAE
                  15.2.3. South Africa
                  15.2.4. Egypt
        15.3. Market Size (USD Million) Forecast for MEA 2022-2028
16. Market Share Analysis and Competitive Landscape   
        16.1. Global Landscape - Key Players, Revenue and Presence
        16.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        16.3. Global Emerging Companies
        16.4. North America - Market Share Analysis and Key Regional Players
        16.5. Europe - Market Share Analysis and Key Regional Players
        16.6. Asia Pacific - Market Share Analysis and Key Regional Players
        16.7. Global Key Player - Growth Matrix           
17. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Disease Indication Portfolio, Financial Layouts)
    17.1 Medtronic
            17.1.1. Company Overview (HQ, Business Segments, Employee Strength)
            17.1.2. Product Portfolio
            17.1.3. SWOT Analysis
            17.1.4. Financial Overview
            17.1.5. Strategic Overview
    17.2 Abbott Laboratories
            17.2.1. Company Overview (HQ, Business Segments, Employee Strength)
            17.2.2. Product Portfolio
            17.2.3. SWOT Analysis
            17.2.4. Financial Overview
            17.2.5. Strategic Overview
    17.3 Boston Scientific
            17.3.1. Company Overview (HQ, Business Segments, Employee Strength)
            17.3.2. Product Portfolio
            17.3.3. SWOT Analysis
            17.3.4. Financial Overview
            17.3.5. Strategic Overview
    17.4 Biotronik
            17.4.1. Company Overview (HQ, Business Segments, Employee Strength)
            17.4.2. Product Portfolio
            17.4.3. SWOT Analysis
            17.4.4. Financial Overview
            17.4.5. Strategic Overview
    17.5 Livanova
            17.5.1. Company Overview (HQ, Business Segments, Employee Strength)
            17.5.2. Product Portfolio
            17.5.3. SWOT Analysis
            17.5.4. Financial Overview
            17.5.5. Strategic Overview
    17.6 Lepu Medical
            17.6.1. Company Overview (HQ, Business Segments, Employee Strength)
            17.6.2. Product Portfolio
            17.6.3. SWOT Analysis
            17.6.4. Financial Overview
            17.6.5. Strategic Overview
    17.7 Shree Pacetronix
            17.7.1. Company Overview (HQ, Business Segments, Employee Strength)
            17.7.2. Product Portfolio
            17.7.3. SWOT Analysis
            17.7.4. Financial Overview
            17.7.5. Strategic Overview
    17.8 Osypka Medical
            17.8.1. Company Overview (HQ, Business Segments, Employee Strength)
            17.8.2. Product Portfolio
            17.8.3. SWOT Analysis
            17.8.4. Financial Overview
            17.8.5. Strategic Overview
    17.9 Medico Spa
            17.9.1. Company Overview (HQ, Business Segments, Employee Strength)
            17.9.2. Product Portfolio
            17.9.3. SWOT Analysis
            17.9.4. Financial Overview
            17.9.5. Strategic Overview
    17.10 Oscor
            17.10.1. Company Overview (HQ, Business Segments, Employee Strength)
            17.10.2. Product Portfolio
            17.10.3. SWOT Analysis
            17.10.4. Financial Overview
            17.10.5. Strategic Overview
18. Pre and Post COVID-19 Impact
        18.1. Positive influence on the healthcare industry
        18.2. The financial disruption of the manufacturing sector
        18.3. Impact of COVID-19 on emerging companies
        18.4. Significant mandates in the healthcare regulations initiated by administrations
        18.5. The overall economic slowdown of the developing and developed nations
19. FutureWise SME Key Takeaway Points for Client

Tables

Figures